The lack of therapeutic benefit of adding hydroxyurea to highly active antiretroviral therapy (HAART).
Omar Y
OY
Gonzalez
John F
JF
Jovanovich
Douglas L
DL
Mayers
Daniel M
DM
Musher
D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D016022:Case-Control Studies; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D012189:Retrospective Studies
D006918:Hydroxyurea